Azienda Ospedaliera "Sant'Andrea"
17
4
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
18%
3 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Role: collaborator
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
Role: lead
ERAS Lazio Network Clinical Registry
Role: collaborator
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
Role: lead
Hyaluronic Acid and Adelmidrol (Hyadrol®) in Patients With Degenerative Joint Disease
Role: collaborator
Phrenic Nerve Infiltration: Pulmonary Expansion and Pain Control
Role: lead
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer
Role: collaborator
Segmentectomy vs Lobectomy
Role: collaborator
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Role: collaborator
Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy
Role: collaborator
Gabapral in Pediatric IBS
Role: lead
Cardioprotective Effect of SGLT2-I in Diabetic Patients With AMI (SGLT2-I AMI PROTECT Study)
Role: collaborator
Tocilizumab in Active Moderate-severe Graves' Orbitopathy
Role: collaborator
Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients
Role: collaborator
Picoprep Split-dose Before Colonoscopy in Children
Role: lead
Sequential Combination Therapy in Bladder Cancer
Role: lead
Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease
Role: collaborator
All 17 trials loaded